We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Onconetix Inc | NASDAQ:ONCE | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 113.57 | 114.49 | 113.60 | 0 | 01:00:00 |
|
|
|
|
|
Delaware
|
|
001-36819
|
|
46-2654405
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|||
3737 Market Street
Suite 1300
Philadelphia, PA
|
|
19104
|
||
(Address of principal executive offices)
|
|
(Zip Code)
|
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Emerging growth company
|
¨
|
|
|
Item 1.01.
|
Entry Into a Material Definitive Agreement.
|
•
|
materially alter the business they conduct;
|
•
|
create, incur, assume or permit to exist any indebtedness that exceeds $25.0 million in the aggregate, except for indebtedness that is subordinated to the Company’s obligations to Wells Fargo under the Credit Agreement; and
|
•
|
permit its liquidity ratio to be less than 2.0 to 1.0.
|
Item 2.03.
|
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
|
|
|
|
|
|
|
|
|
|
|
|
SPARK THERAPEUTICS, INC.
|
||
|
|
|
|
|||
Date: July 9, 2018
|
|
|
|
By:
|
|
/s/ Joseph W. La Barge
|
|
|
|
|
|
|
Joseph W. La Barge
General Counsel
|
1 Year Onconetix Chart |
1 Month Onconetix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions